Sunday, 5 October 2025
  
Login

Australia's most trusted
source of pharma news

Sunday, 05 October 2025
News

Long-running shortage rolls on

 Posted 3 October 2025 

A shortage of both strengths of Pfizer’s PBS-listed Bicillin L-A prefilled syringes for injection has been extended to the end of November 2025.

Pfizer informed the TGA that both strengths would continue to be in shortage due to manufacturing issues. Supply had resumed for the higher strength, 1.2 million-unit syringe, but remained limited, with the sponsor working with wholesalers to support fair distribution of available supplies, the TGA said.

To see the whole article, please login


Latest Jobs
Pharma in Focus  Jobs

Sales & Customer Relations (25)

Clinical & Medical, R&D (8)

Regulatory, Pharmacovigilance & QA (2)

Devices (1)

Other (15)

MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.